Last updated on: 24/09/2013
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: IMS Health
Name of data sourceIMS LifeLink: Longitudinal Prescription Data - Netherlands
Name under which the data source should be displayed in the inventory (e.g short name if one exists)Longitudinal Prescription Data - Netherlands
Name of organisation
1) Department/research groupReal World Evidence Solutions
2) Organisation/affiliationIMS Health
Administrative Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
Scientific Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
2. Description/category
Pharmacy dispensing database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
NDF
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
No events
5. Year of establishment
2007
6. Geographical origin of data
EEA/EFTA countries
Netherlands
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
16,805,000
10 a. Total (cumulative) number of persons with actual data
12,000,000
10 b. Number of persons with active data collection in past calendar year
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
No
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
No
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Netelenbos JC, Geusens PP, Ypma G, Buijs SJ. Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands. Osteoporos Int. 2011 May;22(5):1537-46.
Blok B, Van Kerrebroeck P, Buijs S, De Vries C. Persistence with antimuscarinics in a European study of patients with overactive bladder syndrome. 2009 Presentation. See http://tinyurl.com/3sk6erx
Jones, JK, Davtian, D, Sverdlov, L, and Keyser, M. Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in The Netherlands: a multivariate analysis. Clin. Ther. 1997 Jul-Aug; 19(4):798-810.
